Oral domperidone has no additional effect on chronic functional constipation in children: A randomized clinical trial

Indian Journal of Gastroenterology

Volumn 33, Issue 2, 2014, Pages 125-130

  Dehghani, Seyed Mohsen ^a   Askarian, Mehrdad ^b   Kaffashan, Heidar Ali ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bowel disorder; Children; Polyethylene glycol; Treatment

Indexed keywords

DOMPERIDONE; MACROGOL; PLACEBO; DOPAMINE RECEPTOR BLOCKING AGENT; LAXATIVE; MACROGOL DERIVATIVE;

ARTICLE; CHILD; CONSTIPATION; DEFECATION HABIT; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FECES INCONTINENCE; FEMALE; HARD FECES; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; CHRONIC DISEASE; CONTROLLED STUDY; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CONSTIPATION; DOMPERIDONE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; LAXATIVES; MALE; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME;

EID: 84897374500     PISSN: 02548860     EISSN: 09750711     Source Type: Journal    
DOI: 10.1007/s12664-013-0375-5     Document Type: Article

References (27)

1. van den Berg MM, Benninga M, Di Lorenzo C. Epidemiology of childhood constipation: a systematic review. Am J Gastroenterol. 2006;101: 2401-9.
2. Di Lorenzo C. Childhood constipation: finally some hard data about hard stools! J Pediatr. 2000;136: 4-7.
3. Shaman Rajindrajith S, Devanarayana N. Constipation in children: novel insight into epidemiology, pathophysiology and management. J Neurogastroenterol Motil. 2011;17: 35-47.
4. Baker S, Liptak G, Colletti R, et al. Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2006;43: e1-13.
5. Chung S, Cheng A, Goldman RD. Polyethylene glycol 3350 without electrolytes for treatment of childhood constipation. Can Fam Physician. 2009;55: 481-2.
6. Loening-Baucke V. Controversies in the management of chronic constipation. J Pediatr Gastroenterol Nutr. 2001;32: S38-9.
7. Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL. Cisapride for intestinal constipation. Cochrane Database Syst Rev. 2011;(1): CD007780.
8. Longo WE, Vernava AM 3rd. Prokinetic agents for lower gastrointestinal motility disorders. Dis Colon Rectum. 1993;36: 696-708.
9. Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130: 1527-37.
10. Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Mov Disord. 1997;12: 952-7.
11. Muller-Lissner SA. Bavarian Constipation Study Group. Treatment of chronic constipation with cisapride and placebo. Gut. 1987;28: 1033-8.
12. Tack J, Coremans G, Janssens J. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders. Drug Saf. 1995;12: 384-92.
13. Wiseman LR, Cisapride FD. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs. 1994;47: 116-52.
14. Staiano A, Cucchiara S, Andreotti MR, Minella R, Manzi G. Effect of cisapride on chronic idiopathic constipation in children. Dig Dis Sci. 1991;36: 733-6.
15. Halabi IM. Cisapride in management of chronic pediatric constipation. J Pediatr Gastroenterol Nutr. 1999;28: 199-202.
16. Odeka EB, Sagher F, Miller V, Doig C. Use of cisapride in treatment of constipation in children. J Pediatric Gastroenterol Nutr. 1997;24: 199-203.
17. Nurko S, Garcia-Aranda JA, Worona LB, Zlochisty O. Cisapride for the treatment of constipation in children: a double-blind study. J Pediatr. 2000;136: 35-40.
18. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2006;43: 405-7.
19. Dehghani SM, Imanieh MH, Erjaee A, Moravej H, Matin R, Haghighat M. The role of metoclopramide for treatment of functional constipation in children: a double blind study. J Ped Sci. 2012;4: e 144.
20. Sharma SS, Bhargava N, Mathur SC. Effect of oral erythromycin on colonic transit in patients with idiopathic constipation. A pilot study. Dig Dis Sci. 1995;40: 2446-9.
21. Bellomo-Brandao MA, Collares EF, da-Costa-Pinto EA. Use of erythromycin for the treatment of severe chronic constipation in children. Braz J Med Biol Res. 2003;36: 1391-6.
22. Venkatasubramani N, Rudolph CD, Sood MR. Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study. BMC Gastroenterology. 2008;8: 38.
23. Reddymasu SC, Soykan I, McCallum RW. Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol. 2007;102: 2036-45.
24. Ahmad N, Keith-Ferris J, Gooden E, Abell T. Making a case for domperidone in the treatment of gastrointestinal motility disorders. Curr Opin Pharmacol. 2006;6: 571-6.
25. Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child. 2009;94: 156-60.
26. Dupont C, Leluyer B, Maamri N, et al. Double-blind randomized evaluation of clinical and biological tolerance of polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr. 2005;41: 625-33.
27. Nurko S, Youssef NN, Sabri M, et al. PEG3350 in the treatment of childhood constipation: a multicenter, double-blinded, placebo-controlled trial. J Pediatr. 2008;153: 254-61.